Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Whitehawk Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Restricted Stock Units | 474K | $1.14M | $2.40 | Apr 1, 2025 | Direct |
Aadi Bioscience, Inc. | CHIEF FINANCIAL OFFICER | Common Stock | 23.9K | $56.3K | $2.35 | Mar 3, 2025 | Direct |
Whitehawk Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | Stock Option (right to buy) | 474K | Apr 1, 2025 | Direct | ||
GW PHARMACEUTICALS PLC | Chief Financial Officer | Ordinary Shares | 0 | May 5, 2021 | Direct | ||
GW PHARMACEUTICALS PLC | Chief Financial Officer | Share Options | 0 | May 5, 2021 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
WHWK | Whitehawk Therapeutics, Inc. | Apr 1, 2025 | 2 | $0 | 4 | Apr 3, 2025 | CHIEF FINANCIAL OFFICER |
AADI | Aadi Bioscience, Inc. | Mar 1, 2025 | 3 | -$6.59K | 4 | Mar 3, 2025 | CHIEF FINANCIAL OFFICER |
AADI | Aadi Bioscience, Inc. | Mar 1, 2024 | 3 | $0 | 4 | Mar 4, 2024 | CHIEF FINANCIAL OFFICER |
AADI | Aadi Bioscience, Inc. | Apr 3, 2023 | 1 | $0 | 4 | Apr 4, 2023 | CFO, Interim CEO & President |
AADI | Aadi Bioscience, Inc. | Mar 1, 2023 | 1 | $0 | 4 | Mar 2, 2023 | Chief Financial Officer |
AADI | Aadi Bioscience, Inc. | Sep 26, 2022 | 1 | $250K | 4 | Sep 27, 2022 | Chief Financial Officer |
AADI | Aadi Bioscience, Inc. | Apr 1, 2022 | 1 | $0 | 4 | Apr 5, 2022 | Chief Financial Officer |
AADI | Aadi Bioscience, Inc. | Nov 28, 2021 | 0 | $0 | 3 | Nov 29, 2021 | Chief Financial Officer |
GWPH | GW PHARMACEUTICALS PLC | May 5, 2021 | 12 | $0 | 4 | May 7, 2021 | Chief Financial Officer |